Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
Cocrystal Pharma has appointed James Sapirstein as Chief Executive Officer, effective immediately, replacing co-CEOs Sam Lee and Jim Martin. Sapirstein brings extensive experience in antiviral drug development, having led 23 product launches and served as CEO at Contravir Pharmaceuticals and founding CEO of Tobira Therapeutics.
Key figures
- Product launches led
- 23
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.